Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2026-01-01 @ 5:11 PM
Study NCT ID:
NCT04699292
Status:
RECRUITING
Last Update Posted:
2022-08-30
First Post:
2021-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
International Prospective Registry on Local Treatment Approaches in MLS
Sponsor:
The Netherlands Cancer Institute
Organization:
Study Overview
Official Title:
International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
Status:
RECRUITING
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Detailed Description:
In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| IRBd20-354 | OTHER | The Netherlands Cancer Institute | View |